Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer’s disease and to identify high-risk subgroups-Reference-Cited by-同舟云学术

Using meta-analysis to explain the diversity of results in genetic studies of late-onset Alzheimer’s disease and to identify high-risk subgroups

Published:2001-12 Issue:4 Volume:108 Page:541-554
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Lehmann D.J,Williams J,Mcbroom J,Smith A.D

Publisher

Elsevier BV

Subject

General Neuroscience

Reference104 articles.

1. Genetic polymorphisms and disease;Altshuler;N. Engl. J. Med.,1998

2. The butyrylcholinesterase K variant is a protective factor for sporadic Alzheimer’s disease in women;Alvarez-Arcaya;Acta Neurol. Scand.,2000

3. American Psychiatric Association, 1987. DSM-III-R. Diagnostic and Statistical Manual of Mental Disorders, 3rd Edn. American Psychiatric Association, Washington, DC.

4. Armitage, P., 1983. Statistical Methods in Medical Research. Blackwell Scientific Publications, Oxford.

5. The role of heredity in late-onset Alzheimer disease and vascular dementia: a twin study;Bergem;Arch. Gen. Psychiatry,1997

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population;Cardiovascular Toxicology;2021-11-03

2. Gene Polymorphisms Affecting the Pharmacokinetics and Pharmacodynamics of Donepezil Efficacy;Frontiers in Pharmacology;2020-06-19

3. Synergy between the alteration in the N-terminal region of butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer’s disease;Scientific Reports;2019-03-26

4. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer’s Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects;Journal of Alzheimer's Disease;2016-10-04

5. Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model;Neuroscience;2015-07